Cocoa may stop CVD in diabetes sufferers
Drinking cocoa may impede the development of heart disease in patients suffering from type-2 diabetes, a new survey, reported in the Journal of the American College of Cardiology, claims.
The study discovered that a diet rich in flavanol, found in cocoa, as well as red wine, tea and certain fruits and vegetables, improved blood vessel function in adults with diabetes. Poor function of the blood vessels is thought to be an early stage in the development of CVD, such as atherosclerosis.
The trial was a 30-day, double-masked, clinical study in patients undergoing treatment for type-2 diabetes. It found that three-times-daily doses of 321mg of flavanol, administered in cocoa, not only improved blood vessel function, but also showed a sustained improvement of 30%, comparing day one with day 30.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze